Financial Ratios

CIAN HEALTHCARE LTD.

NSE : NABSE : 542678ISIN CODE : INE05BN01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE21.31-0.48 (-2.2 %)
PREV CLOSE ( ) 21.79
OPEN PRICE ( ) 21.79
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 74000
TODAY'S LOW / HIGH ( )20.92 22.55
52 WK LOW / HIGH ( ) 16.0541.1
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.43-0.910.14-0.030.38
   CEPS(Rs)1.890.121.191.021.78
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)20.5522.9823.2922.1012.66
   Tax Rate(%)10.304.1850.87197.0530.36
Margin Ratios
   Core EBITDA Margin(%)13.227.6512.6713.4212.28
   EBIT Margin(%)8.744.369.5310.4010.08
   Pre Tax Margin(%)1.75-3.610.900.131.47
   PAT Margin (%)1.57-3.460.44-0.131.02
   Cash Profit Margin (%)6.890.443.754.154.76
Performance Ratios
   ROA(%)0.77-1.660.24-0.060.78
   ROE(%)1.98-4.070.62-0.203.70
   ROCE(%)6.162.816.846.909.60
   Asset Turnover(x)0.490.480.550.510.76
   Sales/Fixed Asset(x)1.421.662.381.852.26
   Working Capital/Sales(x)6.695.5216.0414.926.48
Efficiency Ratios
   Fixed Capital/Sales(x)0.700.600.420.540.44
   Receivable days111.30102.0294.72133.96136.24
   Inventory Days183.26165.60111.82113.3090.60
   Payable days309.11293.78170.55215.7195.42
Valuation Parameters
   PER(x)65.000.0080.440.000.00
   PCE(x)14.82162.969.4614.710.00
   Price/Book(x)1.360.830.480.680.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)1.651.401.011.461.02
   EV/Core EBITDA(x)11.6016.247.559.807.15
   EV/EBIT(x)18.6031.1410.3813.939.83
   EV/CE(x)0.790.640.540.620.69
   M Cap / Sales1.040.740.360.610.00
Growth Ratio
   Net Sales Growth(%)5.40-11.4426.88-8.64-5.25
   Core EBITDA Growth(%)74.32-43.3214.38-4.33-32.44
   EBIT Growth(%)108.56-59.3518.27-7.45-42.37
   PAT Growth(%)147.32-796.60551.24-111.05-83.64
   EPS Growth(%)147.31-751.06551.24-108.11-99.87
Financial Stability Ratios
   Total Debt/Equity(x)0.830.750.910.992.24
   Current Ratio(x)1.181.211.091.081.22
   Quick Ratio(x)0.580.610.600.670.87
   Interest Cover(x)1.250.551.101.011.17
   Total Debt/Mcap(x)0.610.901.881.46

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.